Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Current Pharmaceutical Design|January 3, 2013
Invasive aspergillosis in children and adolescentsAndreas H Groll, Dominik Schrey, Athanasios Tragiannidis, et al.Klinische Padiatrie|September 6, 2023
[Therapeutic Strategies In Children And Adolescents With Langerhans Cell Histiocytosis]Anke Elisabeth Barnbrock, Caroline Hutter, Konrad Bochennek, et al.Immunological Investigations|June 2, 2011
Immunotherapy against invasive fungal diseases in stem cell transplant recipientsThomas Lehrnbecher, Lars Tramsen, Ulrike Koehl, et al.Clinical Microbiology Reviews|May 17, 2019
Extended Dosing Regimens for Fungal ProphylaxisThomas Lehrnbecher, Konrad Bochennek, Thomas Klingebiel, et al.Antibiotics (Basel, Switzerland)|July 27, 2022
Infections during Non-Neutropenic Episodes in Pediatric Cancer Patients-Results from a Prospective Study in Two Major Large European Cancer CentersStefan Schöning, Anke Barnbrock, Konrad Bochennek, et al.JCO Oncology Practice|January 23, 2024
No Impact of Dietary Restrictions on the Risk for Infection in Pediatric Patients With Cancer: A Monocenter AnalysisAnke Barnbrock, Jon Salmanton-García, Franziska Lankes, et al.Frontiers in Pediatrics|August 1, 2022
Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future DirectionsTill-Martin Theilen, Yannick Braun, Konrad Bochennek, et al.The Lancet. Oncology|March 1, 2008
Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategiesThomas Lehrnbecher, Ulrike Koehl, Boris Wittekindt, et al.Vaccine|May 6, 2014
Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancerKonrad Bochennek, Regina Allwinn, Rebecca Langer, et al.Pediatric Blood & Cancer|September 12, 2020
Systemic viral infection in children receiving chemotherapy for acute leukemiaConstanze Buus-Gehrig, Konrad Bochennek, Marc T Hennies, et al.Pageof 5